Mt Sinai — New York, New York

Mt Sinai is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Mt Sinai has participated in 7 clinical trials with 3 currently active.

Therapeutic areas: Acute Respiratory Distress Syndrome, Influenza, H1N1 Influenza.

Sponsors: Gordon Bernard, Jazz Pharmaceuticals, Compass Therapeutics.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mt Sinai?

Mt Sinai has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mt Sinai conducted?

Mt Sinai has 7 clinical trials on record, with 3 currently active. Their work covers Acute Respiratory Distress Syndrome, Influenza, H1N1 Influenza.

Is Mt Sinai accredited by Crixeo Health?

Yes — Mt Sinai holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mt Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.